The appearance of the potentially secreted Gsn, Ldha, Prdx2, and Prss23 in CTRL, LH, and CIS + LH, but not in CIS alone, suggests an inhibitory effect of the drug overcome by LH. This evidence concerns the gene GSN and in situ carcinoma.